Ophthalmology And Visual Sciences

Matthew J. Thurtell, MBBS, MSc


Associate Professor of Ophthalmology and Visual Sciences
Associate Professor of Neurology

Contact Information

Primary Office: 11290-E PFP
Iowa City, IA 52242
Phone: 319-356-1951

Email: matthew-thurtell@uiowa.edu
Web: UI Clinical Profile


BS, Medicine, University of Sydney
MBBS, Medicine and Surgery, University of Sydney
MSc, Medicine, University of Sydney

Internship, John Hunter Hospital
Residency, Internal Medicine, Royal Prince Alfred Hospital
Fellowship, FRACP, Advanced Training in Neurology, Fellowship of Royal Australasian College of Physicians
Residency, Neurology, Royal Prince Alfred Hospital
Fellowship, FRACP, Written & Clinical Examinations, Fellowship of Royal Australasian College of Physicians
Fellowship, Neuro-Ophthalmology, Case Western Reserve University
Fellowship, Clinical Neuro-Ophthalmology, Emory University

Licensure and Certifications

Australian Specialist Registration, Medical Board of Australia

Center, Program and Institute Affiliations

Stephen A. Wynn Institute for Vision Research

Selected Publications

Show All

Chen J, Singh N, Brinkley J, Maltry A, Policeni B, Syed N, Allen R, Longmuir R, Thurtell M.  Renal cell carcinoma metastatic to the orbit in a patient with Wegener granulomatosis.  J Neuroophthalmol.  2015. 35(1):94-96.

Thurtell M, Kirby P, Wall M.  Bilateral jugular paragangliomas: a rare cause of raised intracranial pressure.  Neurology.  2014. 82(8):732-3.

NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee .  Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.  JAMA.  2014. 311:1641-1651.

Chen J, Hong S, Kirby P, Policeni B, Carter K, Thurtell M.  Limited Wegener’s granulomatosis presenting with an isolated abduction deficit.  Neuro-Ophthalmology.  2014. 38(3):145-8.

NORDIC IIHT Study Group .  The idiopathic intracranial hypertension treatment trial: design considerations and methods.  J Neuroophhtalmol.  2014. 34:107-117.

Thurtell M, Longmuir R.  Third nerve palsy as the initial manifestation of giant cell arteritis.  J Neuroophthalmol.  2014. 34(3):243-245.

Baldwin A, Thurtell M.  Tumor necrosis factor alpha antagonist precipitating demyelinating disease.  EyeRounds.org.  2013 June 3. 

Thurtell M, Wall M.  Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management.  Curr Treat Options Neurol.  2013. 15(1):1-12.

Thurtell M, Galetta S.  Low-contrast multifocal visual evoked potentials: identifying more shades of gray in MS.  Neurology.  2012. 79(8):732-733.

Anthony S, Thurtell M, Leigh R.  Miller Fisher syndrome mimicking ocular myasthenia gravis.  Optom Vis Sci.  2012. 89(12):e118-e123.

Date Last Modified: 10/13/2016 - 12:50:32